Bausch Health Companies (BHC) Interest Coverage Ratio (2009 - 2026)
Bausch Health Companies (BHC) posted Interest Coverage Ratio of 0.27 for Q2 2026, up 175.35% sequentially from 0.35 in Q1 2026, and down 72.19% YoY from 0.95 in Q2 2025.
Bausch Health Companies (BHC) Interest Coverage Ratio (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Interest Coverage Ratio for 18 years, with the latest figure at 0.27 in Q2 2026.
- Quarterly Interest Coverage Ratio fell 72.19% year-over-year to 0.27 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.32 (down 66.47% YoY) and the FY2025 annual result came in at 0.7, up 3.98% from the prior year.
- Interest Coverage Ratio improved to 0.27 in Q2 2026 per BHC's latest filing, from 0.35 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 1.66 in Q4 2024 and troughed at 0.77 in Q4 2022.
- A 5-year average of 0.5 and a median of 0.48 in 2022 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio slumped 170.38% in 2022, then surged 3391.27% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 0.77 in 2022, then surged by 182.91% to 0.64 in 2023, then jumped by 159.8% to 1.66 in 2024, then decreased by 27.89% to 1.19 in 2025, then plunged by 77.76% to 0.27 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 0.27, 0.35, and 1.19 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.39 Bn | 43.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.69 Bn | 40.04 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.28 Bn | 30.60 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 21.98 Bn | 19.32 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.94 Bn | 18.06 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.94 Bn | 11.41 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Bausch Health Companies | 2.46 Bn | 625.75 Mn | 2.10 Bn | 1.87 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.27 |
| Mar 31, 2026 | 1.72 |
| Dec 31, 2025 | 1.19 |
| Sep 30, 2025 | 1.50 |
| Jun 30, 2025 | 0.19 |
| Mar 31, 2025 | 0.84 |
| Dec 31, 2024 | 1.66 |
| Sep 30, 2024 | 0.92 |
| Jun 30, 2024 | 0.73 |
| Mar 31, 2024 | 0.79 |
| Dec 31, 2023 | 0.64 |
| Sep 30, 2023 | 0.02 |
| Jun 30, 2023 | 1.29 |
| Mar 31, 2023 | 0.57 |
| Dec 31, 2022 | -0.77 |
| Sep 30, 2022 | 0.63 |
| Jun 30, 2022 | 0.24 |
| Mar 31, 2022 | 0.43 |
| Dec 31, 2021 | 1.09 |
| Sep 30, 2021 | 0.71 |